Advanced glycation end-products (AGEs) induce concerted changes in the osteoblastic expression of their receptor RAGE and in the activation of extracellular signal-regulated kinases (ERK)

被引:0
|
作者
Ana M. Cortizo
María G. Lettieri
Daniel A. Barrio
Natalia Mercer
Susana B. Etcheverry
Antonio D. McCarthy
机构
[1] Universidad Nacional de La Plata,Cátedra de Bioquímica Patológica, Facultad de Ciencias Exactas
来源
关键词
advanced glycation end-products; receptor for advanced glycation end-products; extracellular signal-regulated kinases; osteoblasts; bone;
D O I
暂无
中图分类号
学科分类号
摘要
An increase in the interaction between advanced glycation end-products (AGEs) and their receptor RAGE is believed to contribute to the pathogenesis of chronic complications of Diabetes mellitus, which can include bone alterations such as osteopenia. We have recently found that extracellular AGEs can directly regulate the growth and development of rat osteosarcoma UMR106 cells, and of mouse calvaria-derived MC3T3E1 osteoblasts throughout their successive developmental stages (proliferation, differentiation and mineralisation), possibly by the recognition of AGEs moieties by specific osteoblastic receptors which are present in both cell lines. In the present study we examined the possible expression of RAGE by UMR106 and MC3T3E1 osteoblastic cells, by immunoblot analysis. We also investigated whether short-, medium- or long-term exposure of osteoblasts to extracellular AGEs, could modify their affinity constant and maximal binding for AGEs (by 125I-AGE-BSA binding experiments), their expression of RAGE (by immunoblot analysis) and the activation status of the osteoblastic ERK 1/2 signal transduction mechanism (by immunoblot analysis for ERK and P-ERK). Our results show that both osteoblastic cell lines express readily detectable levels of RAGE. Short-term exposure of phenotypically mature osteoblastic UMR106 cells to AGEs decrease the cellular density of AGE-binding sites while increasing the affinity of these sites for AGEs. This culture condition also dose-dependently increased the expression of RAGE and the activation of ERK. In proliferating MC3T3E1 pre-osteoblasts, 24–72 h exposure to AGEs did not modify expression of RAGE, ERK activation or the cellular density of AGE-binding sites. However, it did change the affinity of these binding sites for AGEs, with both higher- and lower-affinity sites now being apparent. Medium-term (1 week) incubation of differentiated MC3T3E1 osteoblasts with AGEs, induced a simultaneous increase in RAGE expression and in the relative amount of P-ERK. Mineralising MC3T3E1 cultures grown for 3 weeks in the presence of extracellular AGEs showed a decrease both in RAGE and P-ERK expression. These results indicate that, in phenotypically mature osteoblastic cells, changes in ERK activation closely follow the AGEs-induced regulation of RAGE expression. Thus, the AGEs-induced biological effects that we have observed previously in osteoblasts, could be mediated by RAGE in the later stages of development, and mediated by other AGE receptors in the earlier pre-osteoblastic stage.
引用
收藏
页码:1 / 10
页数:9
相关论文
共 50 条
  • [21] The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site
    Ishihara, K
    Tsutsumi, K
    Kawane, S
    Nakajima, M
    Kasaoka, T
    FEBS LETTERS, 2003, 550 (1-3) : 107 - 113
  • [22] Crocetin reduces expression of receptor for advanced glycation end products (RAGE) in endothelial cells induced by AGEs
    Xiang, Min
    Qian, Zhiyu
    Zhou, Chenghua
    Liu, Juan
    Li, Wenna
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 310 - 310
  • [23] Diesel particulate matter (DPM) induces receptor for advanced glycation end-products (RAGE) expression by pulmonary macrophages
    Curtis, Cameron S.
    Earley, Tyler D.
    Reynolds, Paul R.
    FASEB JOURNAL, 2012, 26
  • [24] Decreased expression levels of the receptor for advanced glycation end-products (RAGE) mRNA in whole blood of AD patients
    Davaki, P.
    Poulopoulou, C.
    Sgouropoulos, P.
    Orfamotou, F.
    Nikolaou, C.
    Vassilopoulos, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 43 - 44
  • [25] Developmental expression of the receptor for advanced glycation end-products (RAGE) and its response to hyperoxia in the neonatal rat lung
    Lizotte, Pierre-Paul
    Hanford, Lana E.
    Enghild, Jan J.
    Nozik-Grayck, Eva
    Giles, Brenda-Louise
    Oury, Tim D.
    BMC DEVELOPMENTAL BIOLOGY, 2007, 7
  • [26] Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGES (RAGE) expression
    Yamagishi, Sho-ichi
    Matsui, Takanori
    Nakamura, Kazuo
    Inoue, Hiroyoshi
    Takeuchi, Masayoshi
    Ueda, Seiji
    Fukami, Kei
    Okuda, Seiya
    Imaizumi, Tsutomu
    MICROVASCULAR RESEARCH, 2008, 75 (01) : 130 - 134
  • [27] Relationship between the expression of advanced glycation end-products (AGE) and the receptor for AGE (RAGE) mRNA in diabetic nephropathy
    Suzuki, Daisuke
    Toyoda, Masao
    Yamamoto, Naoyuki
    Miyauchi, Masaaki
    Katoh, Mayuko
    Kimura, Moritsugu
    Maruyama, Mayumi
    Honma, Masashi
    Umezono, Tomoya
    Yagame, Mitsunori
    INTERNAL MEDICINE, 2006, 45 (07) : 435 - 441
  • [28] Etomidate ameliorated advanced glycation end-products (AGEs)-induced reduction of extracellular matrix genes expression in chondrocytes
    Sun, Xiaohua
    Zhang, Jizheng
    Li, Yi
    Ren, Wanlu
    Wang, Lijun
    BIOENGINEERED, 2021, 12 (01) : 4191 - 4200
  • [29] Haloperidol and clozapine differentially affect the expression of arrestins, receptor kinases, and extracellular signal-regulated kinase activation
    Ahmed, Mohamed Rafiuddin
    Gurevich, Vsevolod V.
    Dalby, Kevin N.
    Benovic, Jeffrey L.
    Gurevich, Eugenia V.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 325 (01): : 276 - 283
  • [30] Extracellular matrix glycation and receptor for advanced glycation end-products activation: a missing piece in the puzzle of the association between diabetes and cancer
    Rojas, Armando
    Anazco, Carolina
    Gonzalez, Ileana
    Araya, Paulina
    CARCINOGENESIS, 2018, 39 (04) : 515 - 521